Global Electrophysiology (EP) Reporting Unit — Net Sales
Boston Scientific Global Electrophysiology (EP) Reporting Unit — Net Sales increased by 2.9% to $890.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 37.1%, from $649.00M to $890.00M. Over 4 years (FY 2021 to FY 2025), Global Electrophysiology (EP) Reporting Unit — Net Sales shows an upward trend with a 73.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful product adoption, expanded clinical usage, or market share gains in cardiac rhythm management, while a decrease may signal competitive pressure or reduced demand for ablation technologies.
Detailed definition
This metric represents the total revenue generated from the sale of medical devices and technologies used to diagnose an...
Peer comparison
Peers in the medical device industry report similar revenue streams under cardiac rhythm management or electrophysiology segments, often benchmarked against total cardiovascular division performance.
bsx_segment_electrophysiology_net_salesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $95.00M | $86.00M | $101.00M | $118.00M | $152.00M | $148.00M | $167.00M | $177.00M | $193.00M | $190.00M | $240.00M | $300.00M | $428.00M | $527.00M | $649.00M | $730.00M | $840.00M | $865.00M | $890.00M |
| QoQ Change | — | -9.5% | +17.4% | +16.8% | +28.8% | -2.6% | +12.8% | +6.0% | +9.0% | -1.6% | +26.3% | +25.0% | +42.7% | +23.1% | +23.1% | +12.5% | +15.1% | +3.0% | +2.9% |
| YoY Change | — | — | — | — | +60.0% | +72.1% | +65.3% | +50.0% | +27.0% | +28.4% | +43.7% | +69.5% | +121.8% | +177.4% | +170.4% | +143.3% | +96.3% | +64.1% | +37.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Boston Scientific's global electrophysiology (ep) reporting unit — net sales?
- Boston Scientific (BSX) reported global electrophysiology (ep) reporting unit — net sales of $890.00M in Q4 2025.
- How has Boston Scientific's global electrophysiology (ep) reporting unit — net sales changed year-over-year?
- Boston Scientific's global electrophysiology (ep) reporting unit — net sales increased by 37.1% year-over-year, from $649.00M to $890.00M.
- What is the long-term trend for Boston Scientific's global electrophysiology (ep) reporting unit — net sales?
- Over 4 years (2021 to 2025), Boston Scientific's global electrophysiology (ep) reporting unit — net sales has grown at a 73.7% compound annual growth rate (CAGR), from $365.00M to $3.33B.
- What does global electrophysiology (ep) reporting unit — net sales mean?
- The total revenue earned from selling products used to diagnose and treat irregular heartbeats.